Ascend Wellness HoldingsAAWH +4.61%42 Days Inventory is 108.82 as of Mar. 2026, which is 13% above its 10-year median of 96.47. GuruFocus rates AAWH with a GF Score™ of 42/100 and a GF Value™ of $0.64 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 916 Drug Manufacturers companies, Ascend Wellness Holdings ranks better than 80.35% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ascend Wellness Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.84.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ascend Wellness Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.73.
Ascend Wellness Holdings (OTCPK:AAWH) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ascend Wellness Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ascend Wellness Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ascend Wellness Holdings Days Inventory Related Terms
Ascend Wellness Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ascend Wellness Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascend Wellness Holdings Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ascend Wellness Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ascend Wellness Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascend Wellness Holdings (AAWH) has a Days Inventory of 108.82 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ascend Wellness Holdings and its competitors. This is 13% above median its historical median of 96.47. Over the past decade, Ascend Wellness Holdings' Days Inventory has ranged from 87.89 to 127.80. According to the industry distribution chart, Ascend Wellness Holdings ranks #180 out of 916 companies in the Drug Manufacturers industry, placing it in the top 19.7%.
Is Ascend Wellness Holdings' Days Inventory too high?
Ascend Wellness Holdings' current Days Inventory of 108.82 is 13% above median its 10-year median of 96.47. Over the past 10 years, this metric has ranged from a low of 87.89 to a high of 127.80. The Drug Manufacturers industry median Days Inventory is 164.43. Ascend Wellness Holdings' value of 108.82 is 33.8% below this industry median. Based on the distribution chart, Ascend Wellness Holdings ranks #180 out of 916 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Ascend Wellness Holdings has a GF Score™ of 42/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ascend Wellness Holdings' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ascend Wellness Holdings ranks #180 out of 916 companies for Days Inventory. This places Ascend Wellness Holdings in the top 20% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.43. Ascend Wellness Holdings' value of 108.82 is 33.8% below this benchmark. Historically, Ascend Wellness Holdings' own Days Inventory has ranged from 87.89 to 127.80 over the past decade. While the company's 10-year median is 96.47 vs. the industry median of 164.43, Ascend Wellness Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ascend Wellness Holdings's current Days Inventory of 108.82 is 33.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ascend Wellness Holdings and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascend Wellness Holdings's current Days Inventory is 108.82, which is 13% above median its own 10-year median of 96.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascend Wellness Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ascend Wellness Holdings (AAWH) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.64, compared to a current price of $0.47 — trading 26.9% below its estimated fair value. The current Days Inventory is 108.82, which is 13% above median its 10-year median of 96.47 and 33.8% below the Drug Manufacturers industry median of 164.43. Ascend Wellness Holdings' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ascend Wellness Holdings (AAWH), the current Days Inventory is 108.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ascend Wellness Holdings (AAWH) Overvalued in 2026?
Based on GuruFocus' analysis, Ascend Wellness Holdings stock appears to be undervalued.
The current stock price of $0.47 is trading 26.9% below its estimated GF Value™ of $0.64.
GuruFocus considers Ascend Wellness Holdings to be Modestly Undervalued.
Key valuation signals for AAWH:
Days Inventory: 108.82 (13% above median its 10-year median of 96.47)
GF Value™: $0.64 vs. price of $0.47 (26.9% below fair value)
Industry Position: 33.8% below the Drug Manufacturers median (#180 of 916)
No single metric tells the full story. See the AAWH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ascend Wellness Holdings Inc is a vertically integrated multi-state operator focused on adult-use or near-term adult-use cannabis states in limited licenses markets. The company's core business is the cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which it sells through company-owned retail stores and third-party licensed cannabis retail stores. It generates maximum revenue from the retail product segment.
42GF Score
Get the complete analysis for AAWH
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AAWH has been successfully added to your 
